IL134880A0 - A method of diagnosis - Google Patents

A method of diagnosis

Info

Publication number
IL134880A0
IL134880A0 IL13488098A IL13488098A IL134880A0 IL 134880 A0 IL134880 A0 IL 134880A0 IL 13488098 A IL13488098 A IL 13488098A IL 13488098 A IL13488098 A IL 13488098A IL 134880 A0 IL134880 A0 IL 134880A0
Authority
IL
Israel
Prior art keywords
predicting
development
lung damage
damage
diagnosing
Prior art date
Application number
IL13488098A
Other languages
English (en)
Original Assignee
Univ Southern Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8999A external-priority patent/AUPO899997A0/en
Priority claimed from AUPP5062A external-priority patent/AUPP506298A0/en
Application filed by Univ Southern Australia filed Critical Univ Southern Australia
Publication of IL134880A0 publication Critical patent/IL134880A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Control Of Eletrric Generators (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Vehicle Body Suspensions (AREA)
IL13488098A 1997-09-05 1998-09-04 A method of diagnosis IL134880A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8999A AUPO899997A0 (en) 1997-09-05 1997-09-05 A method of diagnosis
AUPP5062A AUPP506298A0 (en) 1998-08-04 1998-08-04 A method of diagnosis - II
PCT/AU1998/000723 WO1999013337A1 (en) 1997-09-05 1998-09-04 A method of diagnosis

Publications (1)

Publication Number Publication Date
IL134880A0 true IL134880A0 (en) 2001-05-20

Family

ID=25645598

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13488098A IL134880A0 (en) 1997-09-05 1998-09-04 A method of diagnosis
IL134880A IL134880A (en) 1997-09-05 2000-03-05 Method of diagnosing lung damage
IL172185A IL172185A0 (en) 1997-09-05 2005-11-24 Method of diagnosis lung damage

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL134880A IL134880A (en) 1997-09-05 2000-03-05 Method of diagnosing lung damage
IL172185A IL172185A0 (en) 1997-09-05 2005-11-24 Method of diagnosis lung damage

Country Status (10)

Country Link
US (1) US8097420B1 (da)
EP (1) EP1018018B1 (da)
JP (2) JP4584445B2 (da)
AT (1) ATE476662T1 (da)
CA (1) CA2303169C (da)
DE (1) DE69841804D1 (da)
DK (1) DK1018018T3 (da)
IL (3) IL134880A0 (da)
NZ (1) NZ503175A (da)
WO (1) WO1999013337A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1866378B (zh) 1996-02-28 2010-09-29 松下电器产业株式会社 光盘重放装置
WO2004077056A1 (en) * 2003-02-27 2004-09-10 Lung Health Diagnostics Pty. Ltd. A method of diagnosis and agents useful for same
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
EP1845379A1 (en) * 2006-04-13 2007-10-17 F. Hoffmann-La Roche AG Means and methods for the differentiation of cardiac and pulmonary causes of shortness of breath
EP1882945A1 (en) 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath
EP2031397A1 (en) 2007-08-30 2009-03-04 F. Hoffmann-La Roche AG Surfactant proteins B and D in differentiating the causes of shortness of breath
CN101938939B (zh) * 2008-02-07 2014-11-26 皇家飞利浦电子股份有限公司 用于测量和预测患者呼吸稳定性的装置
WO2012130731A1 (en) 2011-03-25 2012-10-04 Roche Diagnostics Gmbh MEASUREMENT OF C-TERMINAL proSP-B
CN102552879B (zh) * 2012-03-15 2013-11-06 北京双鹤现代医药技术有限责任公司 肺表面活性提取物与肺表面活性物质相关蛋白a的组合物、制备方法及其制药用途
EP2650684A1 (en) 2012-04-10 2013-10-16 Roche Diagniostics GmbH Pro SP-B and NT-proBNP based diagnosis in patients with pneumonia
EP2615459A1 (en) 2012-04-27 2013-07-17 Roche Diagniostics GmbH proSP-B based diagnosis of distal airway involvement in asthma
EP2866033A1 (en) 2013-10-23 2015-04-29 Roche Diagniostics GmbH Differential diagnosis of acute dyspnea based on C-terminal proSP-B, KL-6 and BNP-type peptides
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
EP3287921B1 (en) * 2016-08-26 2020-11-04 Nxp B.V. Spoken pass-phrase suitability determination

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650147T2 (de) * 1985-05-31 1995-04-06 Teijin Ltd Verfahren zur bestimmung menschlicher lungenoberflächenaktiver substanz und reagenziensatz dazu.
WO1989002075A1 (fr) 1987-09-01 1989-03-09 Teijin Limited Procede d'analyse d'une substance active se trouvant a la surface des poumons chez l'homme
JP2517696B2 (ja) 1990-04-27 1996-07-24 帝人株式会社 肺疾患マ―カ―蛋白の測定法
CA2108451A1 (en) 1991-04-26 1992-10-27 Beverley J. Randle Novel antibodies, and methods for their use
US5670328A (en) 1992-06-09 1997-09-23 Yamasa Corporation Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof
EP0602248B1 (en) * 1992-06-09 2003-11-05 Yamasa Corporation screening of respiratory diseases throgh measurment of HUMAN LUNG SURFACTANT APOPROTEIN D
AU4908799A (en) 1998-07-24 2000-02-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Determination of the hydrophobic pulmonary surfactant protein sp-c
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof

Also Published As

Publication number Publication date
CA2303169C (en) 2009-11-10
IL172185A0 (en) 2009-02-11
DK1018018T3 (da) 2010-11-15
ATE476662T1 (de) 2010-08-15
JP2010197405A (ja) 2010-09-09
EP1018018B1 (en) 2010-08-04
US8097420B1 (en) 2012-01-17
EP1018018A1 (en) 2000-07-12
CA2303169A1 (en) 1999-03-18
DE69841804D1 (de) 2010-09-16
JP2001516057A (ja) 2001-09-25
EP1018018A4 (en) 2004-12-22
WO1999013337A1 (en) 1999-03-18
NZ503175A (en) 2002-11-26
HK1029622A1 (en) 2001-04-06
IL134880A (en) 2006-12-10
JP4584445B2 (ja) 2010-11-24

Similar Documents

Publication Publication Date Title
IL134880A0 (en) A method of diagnosis
DK1328421T3 (da) Fremgangsmåde og apparat til vurdering og forbedring af en førers arbejdspræstation
WO2003069332A3 (en) Detection and/or monitoring of synuclein-related diseases
ZA964819B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
DE69502319D1 (de) System zum Uberprüfen der Anwesenheit des Bedieners für einen Bedienersitz
DE60218863D1 (de) Herz-lungen-überwachungsgerät
EA199800667A1 (ru) Новые фенантридины
DE69935187D1 (de) Diagnoseeinrichtung für Bremskraftverstärker zur optimierten Erkennung von Fehlern des Bremskraftverstärkers
CY1109062T1 (el) Μεθοδοι ανιχνευσεως και αναστολης της αγγειογενεσεως
CA2255023A1 (en) A method and system for monitoring the execution of hybrid source code
WO2000018899A3 (en) Angiotensin converting enzyme homolog and its use
CA2119878A1 (en) Apparatus to determine the operational effectiveness of a machine tool and method therefor
AU6416198A (en) Diagnostic means useful for predictive assessment of human hepatocellular carc inoma disease (hcc), as well as diagnostic methods using the same
DE69404460D1 (de) Zell-test für alzheimersche krankheit
ES2148967T3 (es) Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.
ZA964818B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
FR2344837A1 (fr) Installation d'emission acoustique permettant la detection des defauts de soudage
AU2003217652A8 (en) Methods for continuous performance testing
BR0207548A (pt) Método de controle de poeira automatizado
IL127033A0 (en) A method for early detection of lysosomal storage disorders and a kit for detecting the same
MY120237A (en) Method for the synthesis of quinoline derivatives
ATE200792T1 (de) Reinigungsmittel für anlagen der lebensmittelindustrie, seine verwendung und verfahren zum reinigen dieser anlagen
WO1998041238A3 (en) Methods and kits for treating and diagnosing leiomyomas
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
ES2187552T3 (es) Un sistema de medicion, principalmente ambulatoria, por medio de un electrodo.

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed